QI
AMED

Qtron Investments’s Amedisys AMED Stock Holding History

Qtron Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-931
Closed -$228K – 298
2021
Q2 		$228K Sell
931
-276
-23% -$72.4K 0.06% 316
2021
Q1 		$320K Sell
1,207
-15
-1% -$4.23K 0.09% 259
2020
Q4 		$358K Buy
+1,222
New +$313K 0.1% 250
2019
Q3 		– Sell
-3,634
Closed -$441K – 242
2019
Q2 		$441K Buy
3,634
+448
+14% +$53.2K 0.27% 130
2019
Q1 		$393K Hold
3,186
– – 0.36% 78
2018
Q4 		$373K Buy
+3,186
New +$376K 0.29% 58

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Qtron Investments's AMED Position: Q3 2021 in Review

Qtron Investments sold out of Amedisys (AMED) in Q3 2021, closing a stake of 931 shares — an estimated $228K sold.

Qtron Investments first reported a position in AMED in Q4 2018 and held it in 6 quarters. The position peaked at $441K in Q2 2019. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Qtron Investments reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Qtron Investments sold 931 Amedisys shares in Q3 2021, an estimated $228K.
  • Qtron Investments first reported a position in Amedisys in Q4 2018 and held it in 6 quarters.
  • Qtron Investments's Amedisys position peaked at $441K in Q2 2019.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Qtron Investments's 13F filing for Q3 2021, filed 12 Nov 2021.